Search Count: 15
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-08513
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-11-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: QJY |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-11-18
Ligands: QJY
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-08613
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-11-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: QK1 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-11-18
Ligands: QK1
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-087-13
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2019-05-01 Classification: HYDROLASE/INHIBITOR Ligands: FQ4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-05-01
Ligands: FQ4
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-084-13
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2019-05-01 Classification: HYDROLASE/INHIBITOR Ligands: FQ1 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-05-01
Ligands: FQ1
 |
Hiv-1 Wild Type Protease With Grl-100-13A (A Crown-Like Oxotricyclic Core As The P2-Ligand With The Sulfonamide Isostere As The P2' Group)
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2017-05-03 Classification: hydrolase/hydrolase inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2017-05-03
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-0476
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-01-13 Classification: Hydrolase/Hydrolase Inhibitor Ligands: 52U |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-01-13
Ligands: 52U
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-015
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-01-13 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 52W |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-01-13
Ligands: 52W
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-085
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-01-13 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 52Z |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-01-13
Ligands: 52Z
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-097
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-01-13 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 53F |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-01-13
Ligands: 53F
 |
Crystal Structure Of Hiv-1 Protease Inhibitors Containing Substituted Fused-Tetrahydropyranyl Tetrahydrofuran As P2-Ligand Grl-004-11A
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.22 Å Release Date: 2015-10-28 Classification: HYDROLASE Ligands: 5B7, NA, CL, ACT |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2015-10-28
Ligands: 5B7, NA, CL, ACT
 |
Crystal Structure Of Hiv-1 Protease Inhibitor Grl-105-11A Containing Substituted Fused-Tetrahydropyranyl Tetrahydrofuran As P2-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2015-10-28 Classification: HYDROLASE Ligands: 5B5, NA, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2015-10-28
Ligands: 5B5, NA, CL
 |
Hiv-1 Wild Type Protease With Grl-011-11A (A Methylamine Bis-Tetrahydrofuran P2-Ligand, Sulfonamide Isostere Derivate)
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:1.34 Å Release Date: 2015-09-09 Classification: HYDROLASE/HYDROLASE Inhibitor |
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION
Release Date: 2015-09-09
 |
Hiv-1 Wild Type Protease With Grl-047-11A (A Methylamine Bis-Tetrahydrofuran P2-Ligand, 4-Amino Sulfonamide Derivative)
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2015-09-09 Classification: HYDROLASE/HYDROLASE Inhibitor Ligands: 4UX, NA, CL, ACT |
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION
Release Date: 2015-09-09
Ligands: 4UX, NA, CL, ACT
 |
Crystal Structure Of Wild-Type Hiv-1 Protease With Novel Tricyclic P2-Ligands Grl-0739A
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2013-09-04 Classification: Hydrolase/Hydrolase Inhibitor Ligands: G79, CL, ACT, NA, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-09-04
Ligands: G79, CL, ACT, NA, GOL
 |
Hiv-1 Wild Type Protease With A Substituted Bis-Tetrahydrofuran Inhibitor, Grl-044-10A
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2011-12-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: G04, NA, CL, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2011-12-21
Ligands: G04, NA, CL, GOL